Biomarker development for pancreatic ductal adenocarcinoma using integrated analysis of mRNA and miRNA expression

Proceedings - 2014 IEEE International Conference on Bioinformatics and Biomedicine, IEEE BIBM 2014

Volumn , Issue , 2014, Pages 273-278

  Kwon, Min Seok ^a   Kim, Yongkang ^a   Lee, Seungyeoun ^b   Namkung, Junghyun ^c   Yun, Taegyun ^c   Yi, Sung Gon ^c   Han, Sangjo ^c   Kang, Meejoo ^d   Kim, Sun Whe ^d   Jang, Jin Young ^d   Park, Taesung ^a  

^a Seoul National University   (South Korea)

^b Sejong University   (South Korea)

^c SK Telecom   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Biomarker development; miRNA expression; mRNA expression; Pancreatic ductal adenocarcinoma (PDAC); prediction model

Indexed keywords

EID: 84922779661     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BIBM.2014.6999167     Document Type: Conference Paper

References (35)

1. A. Chan, E. P. Diamandis, and I. M. Blasutig, "Strategies for discovering novel pancreatic cancer biomarkers," J Proteomics, vol. 81, pp. 126-34, Apr 9 2013.
2. T. A. Farazi, J. I. Hoell, P. Morozov, and T. Tuschl, "MicroRNAs in human cancer," Adv Exp Med Biol, vol. 774, pp. 1-20, 2013.
3. H. Hermeking, "The miR-34 family in cancer and apoptosis," Cell Death Differ, vol. 17, pp. 193-9, Feb 2010.
4. C. D. Johnson, A. Esquela-Kerscher, G. Stefani, M. Byrom, K. Kelnar, D. Ovcharenko, et al., "The let-7 microRNA represses cell proliferation pathways in human cells," Cancer Res, vol. 67, pp. 7713-22, Aug 15 2007.
5. A. Kuehbacher, C. Urbich, and S. Dimmeler, "Targeting microRNA expression to regulate angiogenesis," Trends Pharmacol Sci, vol. 29, pp. 12-5, Jan 2008.
6. M. S. Nicoloso, R. Spizzo, M. Shimizu, S. Rossi, and G. A. Calin, "MicroRNAs-the micro steering wheel of tumour metastases," Nat Rev Cancer, vol. 9, pp. 293-302, Apr 2009.
7. D. P. Bartel and C. Z. Chen, "Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs," Nat Rev Genet, vol. 5, pp. 396-400, May 2004.
8. T. Sun, X. Kong, Y. Du, and Z. Li, "Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications," Gastroenterol Res Pract, vol. 2014, p. 386561, 2014.
9. A. M. Mezlini, B. Wang, A. Deshwar, Q. Morris, and A. Goldenberg, "Identifying cancer specific functionally relevant miRNAs from gene expression and miRNA-to-gene networks using regularized regression," PLoS One, vol. 8, p. e73168, 2013.
10. T. R. Donahue, L. M. Tran, R. Hill, Y. Li, A. Kovochich, J. H. Calvopina, et al., "Integrative survival-based molecular profiling of human pancreatic cancer," Clin Cancer Res, vol. 18, pp. 1352-63, Mar 1 2012.
11. L. Badea, V. Herlea, S. O. Dima, T. Dumitrascu, and I. Popescu, "Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia," Hepatogastroenterology, vol. 55, pp. 2016-27, Nov-Dec 2008.
12. H. Pei, L. Li, B. L. Fridley, G. D. Jenkins, K. R. Kalari, W. Lingle, et al., "FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt," Cancer Cell, vol. 16, pp. 259-66, Sep 8 2009.
13. S. Eckerle, V. Brune, C. Doring, E. Tiacci, V. Bohle, C. Sundstrom, et al., "Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma," Leukemia, vol. 23, pp. 2129-38, Nov 2009.
14. D. T. Chen, A. Nasir, A. Culhane, C. Venkataramu, W. Fulp, R. Rubio, et al., "Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue," Breast Cancer Res Treat, vol. 119, pp. 335-46, Jan 2010.
15. E. Wurmbach, Y. B. Chen, G. Khitrov, W. Zhang, S. Roayaie, M. Schwartz, et al., "Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma," Hepatology, vol. 45, pp. 938-47, Apr 2007.
16. J. Hou, J. Aerts, B. den Hamer, W. van Ijcken, M. den Bakker, P. Riegman, et al., "Gene expression-based classification of non-small cell lung carcinomas and survival prediction," PLoS One, vol. 5, p. e10312, 2010.
17. T. Barrett, S. E. Wilhite, P. Ledoux, C. Evangelista, I. F. Kim, M. Tomashevsky, et al., "NCBI GEO: archive for functional genomics data sets-update," Nucleic Acids Res, vol. 41, pp. D991-5, Jan 2013.
18. S. D. Hsu, Y. T. Tseng, S. Shrestha, Y. L. Lin, A. Khaleel, C. H. Chou, et al., "miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions," Nucleic Acids Res, vol. 42, pp. D78-85, Jan 2014.
19. B. P. Lewis, C. B. Burge, and D. P. Bartel, "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets," Cell, vol. 120, pp. 15-20, Jan 14 2005.
20. M. Kertesz, N. Iovino, U. Unnerstall, U. Gaul, and E. Segal, "The role of site accessibility in microRNA target recognition," Nat Genet, vol. 39, pp. 1278-84, Oct 2007.
21. C. L. Plaisier, J. C. Bare, and N. S. Baliga, "miRvestigator: web application to identify miRNAs responsible for co-regulated gene expression patterns discovered through transcriptome profiling," Nucleic Acids Res, vol. 39, pp. W125-31, Jul 2011.
22. C. L. Plaisier, M. Pan, and N. S. Baliga, "A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers," Genome Res, vol. 22, pp. 2302-14, Nov 2012.
23. P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, et al., "Cytoscape: a software environment for integrated models of biomolecular interaction networks," Genome Res, vol. 13, pp. 2498-504, Nov 2003.
24. H. Mi, A. Muruganujan, J. T. Casagrande, and P. D. Thomas, "Largescale gene function analysis with the PANTHER classification system," Nat Protoc, vol. 8, pp. 1551-66, Aug 2013.
25. S. Y. Choi, H. C. Shin, S. Y. Kim, and Y. W. Park, "Role of TMPRSS4 during cancer progression," Drug News Perspect, vol. 21, pp. 417-23, Oct 2008.
26. M. S. Kim, S. V. Kuppireddy, S. Sakamuri, M. Singal, D. Getnet, H. C. Harsha, et al., "Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs)," J Proteome Res, vol. 11, pp. 5556-63, Nov 2 2012.
27. A. P. Sokolenko, D. R. Bulanova, A. G. Iyevleva, S. N. Aleksakhina, E. V. Preobrazhenskaya, A. O. Ivantsov, et al., "High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients," Int J Cancer, vol. 134, pp. 2352-8, May 15 2014.
28. L. Cheng, S. Yang, Y. Yang, W. Zhang, H. Xiao, H. Gao, et al., "Global gene expression and functional network analysis of gastric cancer identify extended pathway maps and GPRC5A as a potential biomarker," Cancer Lett, vol. 326, pp. 105-13, Dec 29 2012.
29. S. Larsen, T. Yokochi, E. Isogai, Y. Nakamura, T. Ozaki, and A. Nakagawara, "LMO3 interacts with p53 and inhibits its transcriptional activity," Biochem Biophys Res Commun, vol. 392, pp. 252-7, Feb 12 2010.
30. M. Aoyama, T. Ozaki, H. Inuzuka, D. Tomotsune, J. Hirato, Y. Okamoto, et al., "LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma," Cancer Res, vol. 65, pp. 4587-97, Jun 1 2005.
31. Y. Jiang, M. Liu, Z. Li, and Y. Jiang, "Discovery of novel candidate oncogenes in pancreatic carcinoma using high-throughput microarrays," Hepatogastroenterology, vol. 60, pp. 1825-32, Nov-Dec 2013.
32. H. Kosanam, I. Prassas, C. C. Chrystoja, I. Soleas, A. Chan, A. Dimitromanolakis, et al., "Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues," Mol Cell Proteomics, vol. 12, pp. 2820-32, Oct 2013.
33. R. Garzon, G. Marcucci, and C. M. Croce, "Targeting microRNAs in cancer: rationale, strategies and challenges," Nat Rev Drug Discov, vol. 9, pp. 775-89, Oct 2010.
34. N. Nishida, H. Yano, T. Nishida, T. Kamura, and M. Kojiro, "Angiogenesis in cancer," Vasc Health Risk Manag, vol. 2, pp. 213-9, 2006.
35. X. Zhang, "Biomarker validation: movement towards personalized medicine," Expert Rev Mol Diagn, vol. 7, pp. 469-71, Sep 2007.